Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002017131-24-000001
Filing Date
2024-03-26
Accepted
2024-03-26 16:31:50
Documents
1
Effectiveness Date
2024-03-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7006
  Complete submission text file 0002017131-24-000001.txt   8085
Mailing Address 58 EDGEWOOD AVE NE LAB 124 ATLANTA GA 30303
Business Address 58 EDGEWOOD AVE NE LAB 124 ATLANTA GA 30303 7273897725
Andson Biotech Inc. (Filer) CIK: 0002017131 (see all company filings)

EIN.: 874041250 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-508686 | Film No.: 24784096